Higher levels of ACh in CeD may be related to increased acetylcholine biosynthesis from acetyl-CoA and inhibition or inactivation of acetylcholinesterase (AChE), the enzyme responsible for the ACh degradation in cholinergic neurons [74]. The gene discussed is ACHE; the disease is cranioectodermal dysplasia.